Carbamazepine is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. It is used in schizophrenia along with other medications and as a second-line agent in bipolar disorder
Anant Labs manufacture and furnish high quality Carbamazepine impurities for global markets. Our Carbamazepine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
carbamazepine298-46-4Tegretol5H-Dibenz[b,f]azepine-5-carboxamideFinlepsinTegretalBistonCarbamazepenEquetroTelesminCarbazepineTimonilCarbamezepineKarbamazepinCarbatrolNeurotolStazepineEpitolCarbamazepinTegretol-XrTerilGeigy 32883CarbamazepinaCarbamazepinumCarnexivSirtalbenzo[b][1]benzazepine-11-carboxamide5-Carbamyl-5H-dibenzo(b,f)azepine5-Carbamoyl-5H-dibenzo(b,f)azepineG-328835H-Dibenz(b,f)azepine-5-carboxamideKarbelexNeurotopCarbamazepine Anhydrous5-Carbamoyl-5H-dibenz(b,f)azepineG 328835-Carbamoyl-5H-dibenz[b,f]azepineDTXSID4022731Carbamazepine extended releaseNSC-169864CHEBI:3387NSC16986433CM23913MDTXCID9027315-20-08-00247 (Beilstein Handbook Reference)Tegretol XRbenzo(b)(1)benzazepine-11-carboxamide2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamideEpimazCarbagen srEpimaz retSirtal retTegretol chewtabTeril retArbil mrCarbamazepine ER2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamideTimonil 200 retTimonil 400 retRefChem:5646Tegretol prolonged releaseN03AF015H-Dibenzo(b,f)azepin-5-carboxamide2-azatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide206-062-7Carbamat5H-Dibenzo[b,f]azepine-5-carboxamideLexinAmizepinBipotrolCalepsinMFCD00005073TrimonilNSC 169864CHEMBL1085-Carbamyldibenzo(b,f)azepineMLS0000696525-Carbamoyldibenzo(b,f)azepineCBZStazepindibenzo[b,f]azepine-5-carboxamides1693NCGC00015234-11CAS-298-46-4SMR0000582015H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity ACarbelanTegretol CrCarbamazepinum [INN-Latin]Carbamazepina [INN-Spanish]SMR001227191HSDB 3019SR-01000000229Carbatrol extended-releaseEINECS 206-062-7BRN 1246090CarbmazepineNeurotop retardCarbamazepine?Carbagamma;Neurotop;Tegretol;Atretol;Carbium;Prozine;Timonil;Carbamazepine RSEpimaz;Epitol;Sirtal;UNII-33CM23913MCarba;Teril;Carbamazepine CRSTegretol (TN)N6WPrestwick_104Equetro (TN)Carbamazepine, powderOpera_ID_72Spectrum_000096Carbamazepine [USAN:USP:INN:BAN:JAN]Carbamazepine (Standard)Prestwick0_000052Prestwick1_000052Prestwick2_000052Prestwick3_000052Spectrum2_000125Spectrum3_000325Spectrum4_000262Spectrum5_000936Carbamazepine (Carbatrol)Lopac-C-4024ChemDiv1_018966CARBAMAZEPINE [MI]CBChromo1_000350Epitope ID:174842Iminostilbene-N-carboxamideCARBAMAZEPINE [INN]CARBAMAZEPINE [JAN]CARBAMAZEPINE [HSDB]CARBAMAZEPINE [USAN]Lopac0_000292Oprea1_790775SCHEMBL21639BSPBio_000203BSPBio_001929CARBAMAZEPINE [VANDF]KBioGR_000724KBioSS_000516MLS001055475MLS001074172MLS002548877BIDD:GT0479CARBAMAZEPINE [MART.]DivK1c_000388DivK1c_003750SPECTRUM1500159SPBio_000170SPBio_002124CARBAMAZEPINE [USP-RS]CARBAMAZEPINE [WHO-DD]CARBAMAZEPINE [WHO-IP]BPBio1_000225GTPL5339orb1310147orb3139395SCHEMBL29360181SCHEMBL29433237HMS501D10HMS640O02HY-B0246RKBio1_000388KBio2_000516KBio2_003084KBio2_005652KBio3_001149WLN: T C676 BNJ BVZCarbamazepine (JP18/USP/INN)CBZ;NSC 169864SPD-417Carbamazepine - Bio-X trade markCarbamazepine, analytical standardNINDS_000388Carbamazepine, 1mg/ml in MethanolGLXC-06091HMS1568K05HMS1920I17HMS2090M07HMS2091O19HMS2095K05HMS2233G16HMS3039K09HMS3259B21HMS3260L06HMS3372J13HMS3657G03HMS3712K05HMS3747E03HMS5079B14HMS6018K08Pharmakon1600-01500159CARBAMAZEPINE [ORANGE BOOK]HY-B0246MSK10039PXB902215-Carbomoyl-5H-dibenzo(b,f)azepineCARBAMAZEPINE [EP MONOGRAPH]CARBAMAZEPINE [USP IMPURITY]Tox21_110104Tox21_202273Tox21_300195Tox21_500292AC2074BBL005372BDBM50003659CARBAMAZEPINE [USP MONOGRAPH]CCG-38931EBC-11073NSC755920STK1773575H-Dibenz[b,f]azepine-5-carboxamineCarbamazepine 1.0 mg/ml in MethanolCARBAMAZEPINUM [WHO-IP LATIN]AKOS003235644AKOS025397243Tox21_110104_1AC-9538DB00564KS-5146LP00292NC00679NSC-755920SDCCGSBI-0050280.P005CDS1_002710IDI1_0003885H-Dibenzo[b,f]azepine-5-carboxamide #NCGC00015234-01NCGC00015234-02NCGC00015234-03NCGC00015234-04NCGC00015234-05NCGC00015234-06NCGC00015234-07NCGC00015234-08NCGC00015234-09NCGC00015234-10NCGC00015234-12NCGC00015234-13NCGC00015234-14NCGC00015234-15NCGC00015234-16NCGC00015234-18NCGC00015234-19NCGC00015234-33NCGC00023877-03NCGC00023877-04NCGC00023877-05NCGC00023877-06NCGC00023877-07NCGC00023877-08NCGC00253982-01NCGC00259822-01NCGC00260977-01BC166161ST075773SY002823Carbamazepine; Oxcarbazepine EP Impurity ASBI-0050280.P004DB-047659Dibenzo[b,f]azepine-5-carboxylic acid amideEU-0100292NS00000207Oxcarbazepine EP Impurity A (Carbamazepine)SW220141-1T0943EN300-21678OXCARBAZEPINE IMPURITY A [EP IMPURITY]BIM-0050280.0001C 4024C06868Carbamazepine, meets USP testing specificationsD002525H-Dibenz(b,f)azepine-5-carboxamide maleic acid5H-Dibenz(b,f)azepine-5-carboxamide oxalic acidAB00051931-17AB00051931-18AB00051931_19AB00051931_20F242225Q410412carbamazepine host structure with maleic acid removedcarbamazepine host structure with oxalic acid removedSR-01000000229-2SR-01000000229-4SR-01000000229-75H-Dibenz(b,f)azepine-5-carboxamide DL-tartaric acidBRD-K71799949-001-06-7BRD-K71799949-001-35-6BRD-K71799949-001-36-4F0348-2551Z104508594carbamazepine host structure with DL-tartaric acid removedDibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine)carbamazepine host structure with 4-hydroxybenzoic acid removedCarbamazepine, British Pharmacopoeia (BP) Reference StandardCarbamazepine, European Pharmacopoeia (EP) Reference StandardCarbamazepine, United States Pharmacopeia (USP) Reference Standard2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamideCarbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material